Oxapam

Quick links to important sections

Oxapam

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxapam

Quick Facts

Property Description
Active Ingredient Oxazepam
Form Capsule or Tablet
Pharmacological Class Benzodiazepine / CNS Depressant
General Purpose Relieves tension and anxiety
Origin Synthetic compound

What Type of Medicine is Oxapam and What is its Composition?

Oxapam is a trade name for a prescription medication whose active ingredient is Oxazepam, which belongs to the widely recognized Benzodiazepine class of drugs. This compound is a synthetic, single-ingredient substance developed specifically to influence the nervous system. The inclusion of Oxazepam places the medicine within the broader pharmacological class of Central Nervous System (CNS) Depressants. Oxazepam is an effective anxiolytic agent and is unique among some related benzodiazepines as it is an active metabolite of other drugs like diazepam, making it useful for specific patient needs. This chemical is structurally defined as a 3-hydroxybenzodiazepine, a subtype known for its short-to-intermediate duration of action compared to more commonly prescribed long-acting compounds.


What Forms of Oxazepam Are Available and How Does it Relieve Tension?

Oxazepam is primarily prepared for the oral route of administration, presented in solid pharmaceutical forms, typically as capsules or tablets. The medication's general purpose is to help relieve symptoms associated with excessive tension and anxiety. Because it is a CNS depressant, Oxazepam works by slowing down overactivity within the nervous system, which helps to settle feelings of agitation and nervousness. This calming effect is recognized for its benefit in situations involving acute emotional stress or heightened restlessness. The availability of Oxazepam as capsules and tablets offers a conventional and controlled method of delivery. The drug is a recognized anxiolytic agent, emphasizing its established use to diminish nervousness.

Regulatory References

  1. Oxazepam: MedlinePlus Drug Information
  2. WHO Model Lists of Essential Medicines

What side effects are possible with Oxapam?

Possible Side Effects and Safety Information

The safety profile for Oxapam, based on regulatory documentation, details adverse reactions primarily affecting the central nervous system (CNS) and psychiatric function.

Documented Adverse Reactions

Side effects are officially classified by frequency and body system. Reactions classified as Common include drowsiness, dizziness, and headache, often noted during the first few days of therapy. Other documented effects involve the psychiatric system (e.g., disorientation, lethargy), the gastrointestinal system (nausea), and the vascular system (hypotension). Effects such as ataxia (unsteady gait), slurred speech, skin rashes, and jaundice have been reported, but their frequency is Not Known based on current official data.

Serious Safety Considerations

Official regulatory labeling documents several serious safety constraints. Continued use carries a documented risk of developing physical dependence and acute, potentially life-threatening withdrawal reactions, including seizures, upon rapid reduction or cessation. A major safety restriction concerns concomitant use with opioids, which may result in profound sedation, respiratory depression, coma, and death. Furthermore, paradoxical reactions, such as increased aggression, agitation, or rage, are explicitly documented as potential severe adverse reactions.

Population-Specific Safety Notes

The medicine's safety profile notes specific considerations for certain patient groups. Older adults are at an increased risk of CNS adverse effects like dizziness and muscle weakness, contributing to a higher documented risk of falls. Use during pregnancy is associated with risks of neonatal sedation and neonatal withdrawal syndrome in the newborn. Due to the drug's elimination pathway, caution is generally advised for patients with existing liver impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Oxapam (Oxazepam) primarily results in Central Nervous System (CNS) depression. Documented clinical manifestations of overexposure include drowsiness, confusion, stupor, ataxia (uncoordinated movement), and slurred speech. Overdose carries the risk of life-threatening outcomes, which is increased when the medication is ingested with other CNS depressants. These severe outcomes include respiratory depression, apnea (stopped breathing), and profound sedation that may progress to coma and, rarely, death.

Regulatory guidance mandates seeking immediate medical attention or calling a poison control center right away. Urgent medical help is required when specific severe symptoms occur, such as shallow or stopped breathing, seizures, or unresponsiveness (the inability to be awakened).

Management of overdose is symptomatic and supportive, focused on maintaining the airway, breathing, and circulation. The specific antagonist Flumazenil is available; however, regulatory documents caution that its administration may precipitate acute withdrawal seizures in chronic benzodiazepine users. Elderly patients are noted to be more susceptible to severe CNS effects and hypotension during an overdose event.

Therapeutic Uses of Oxapam

What Oxapam Treats: Main Uses and Benefits

Oxapam is used to provide symptomatic support across domains where additional symptomatic support is needed. It is considered relevant in conditions characterized by periods of heightened symptoms and distress.

The medication is commonly applied in addressing significant anxiety disorders, for the short-term relief of symptoms of anxiety associated with depression, and for the management of symptoms during acute alcohol withdrawal. It helps to manage symptoms that interfere with daily functioning, such as persistent nervousness, excessive inner tension, and psychomotor agitation.

A key therapeutic benefit is that the medication supports the patient during difficult episodes by easing distress and contributing to improved comfort during symptomatic periods. This supportive relief is particularly relevant when symptoms become temporarily overwhelming.

“The application of Oxapam is primarily focused on offering supportive relief in situations involving heightened anxiety, tension, or acute neuro-autonomic symptoms like tremulousness.”

Quick Fact: Relief for Tension and Agitation Oxapam is applied when symptoms create noticeable physiological strain, assisting with maintaining functional stability in adults and older patients experiencing anxiety and restlessness.

Regulatory References

  1. National Institutes of Health (NIH) DailyMed

Eligibility and Restrictions for Use

Who Can and Cannot Use Oxapam?

Eligibility for Oxapam (Oxazepam) is strictly determined by official regulatory documents, defining who may use the medicine and who is formally prohibited.

Contraindicated Populations and Conditions

Use is contraindicated in patients with a known hypersensitivity to oxazepam or any other benzodiazepine. The medicine must not be used by individuals with conditions that compromise respiratory or neurological function, including severe respiratory insufficiency, sleep apnoea syndrome, acute narrow-angle glaucoma, and Myasthenia Gravis. Regulatory labeling also specifies that Oxapam is not recommended for treating phobic or obsessional states or chronic psychosis.

Age and Physiological Restrictions

Safety and effectiveness have not been established for pediatric patients, and use in children is generally not recommended. While older adults are eligible, they are considered a conditional-use population and are subject to specific caution. Oxapam should not be used during pregnancy, especially during the first and third trimesters, and should not be administered to breastfeeding mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Oxapam (Oxazepam) emphasizes pharmacodynamic interactions, which involve combined effects on the central nervous system (CNS), rather than metabolic or enzyme-based interactions.

Interaction Scope

Category Official Regulatory Information
Medicinal product categories with documented interactions Opioid Analgesics, Other Central Nervous System (CNS) Depressants (including sedatives, anxiolytics, and general anesthetics).
Mechanistic basis of interactions Pharmacodynamic reinforcement resulting in additive or potentiated CNS depressant effects.
Population-specific interaction notes Elderly patients are officially noted to be at greater risk for consequences of the pharmacodynamic interaction, such as oversedation.

Resulting Interaction Structure

Co-administration with Opioid Analgesics is subject to a severe regulatory restriction. This combination carries the risk of profound sedation, respiratory depression, coma, and death, and must be reserved for patients where alternative treatment options are inadequate.

Concomitant use with Other CNS Depressants causes additive or potentiated CNS depression. Furthermore, the effects of Alcohol (Ethanol) are considered officially additive to the effects of Oxapam. The official profile does not explicitly detail specific timing-based separation rules or significant pharmacokinetic interactions involving CYP enzymes.

Mechanism of Action

Pharmacodynamics: GABA A Receptor Modulation

Oxapam functions within the central nervous system (CNS) as a positive allosteric modulator of the gamma-aminobutyric acid type A ( GABA A) receptor. This mechanism involves the drug binding to a specific site on the receptor complex, distinct from the primary GABA binding site. This interaction potentiates the inhibitory effects of the naturally occurring neurotransmitter, GABA.

This molecular modification increases the frequency of the GABA A receptor's integral chloride ion channel opening. The resulting increased influx of chloride ions into the neuron leads to hyperpolarization of the neuronal membrane, which decreases the cell's excitability. This enhancement of inhibitory tone occurs across key neural circuits, particularly in the limbic system and cortex. The resulting decrease in widespread neuronal discharge and limiting of increased neuronal activity within affected circuits constitutes the core system-level physiological modulation.

Dosage and Administration Information

How Oxapam (Oxazepam) is Used: Administration Guidelines

Oxapam is administered exclusively via the oral route, typically supplied as capsules or tablets in strengths such as 10 mg, 15 mg, and 30 mg. Usage is based on the principle of using the lowest effective dose for the shortest period.


Standard Dosing and Frequency

The standard adult dosing schedule specifies taking the medicine multiple times daily, usually three or four times a day (TID or QID), within prescribed dose ranges of 15 mg to 30 mg per dose. For issues related to sleep, the dose is sometimes scheduled for administration one hour before retiring. Guidelines cover handling a missed dose: it should be taken as soon as remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose must be skipped to avoid a double dose.


Duration and Special Populations

Oxapam is designated for short-term use only. The maximum recommended duration for use is often specified as not exceeding four weeks, or up to four months, as its long-term use is not fully assessed.

Population-Specific Adjustments are necessary for certain groups. For older adults, guidance specifies starting treatment with a lower dose, such as 10 mg three times daily, and maintaining a reduced range (e.g., 10 mg to 20 mg, three or four times daily). Similarly, lower doses may be necessary for patients with known hepatic or renal impairment. Upon discontinuation, the medication must be withdrawn gradually (tapered) to adhere to established procedural guidelines.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Oxapam

Evidence for the Short-Term Management of Anxiety Symptoms

Research into Oxapam's application for anxiety relief has explored short-term Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews that examine how anxiety symptoms change over a defined period. These studies were conducted during periods of increased symptom activity and focused on adults experiencing anxiety disorders.

The main focus of these studies was to monitor key outcomes reflecting daily functioning or activity level and symptom change. Researchers used standardized clinical rating scales to assess changes in symptom intensity for anxiety, agitation, and excessive inner tension over the study period. Some trials described patterns observed in the studies that involved measured changes in psychomotor agitation and tension ratings over the short term.

Despite the research base for short-term use, the long-term effects are not fully established. Follow-up durations were limited in the systematic clinical trials. There is limited information for long-term outcomes regarding the durability of relief or the maintenance of daily-life functioning beyond the initial few months of use.


Evidence for Managing Symptoms During Acute Alcohol Withdrawal

Oxapam was studied for its use in managing the symptoms that arise during acute alcohol withdrawal, a condition characterized by periods of heightened symptoms and temporary physiological imbalance. The research base here is built upon short-term RCTs that often studies monitored against placebo or other related medications.

The studies monitored outcomes describing episodic or acute changes, such as patterns related to neuro-autonomic symptoms like body tremors (tremulousness) and high levels of anxiety. Research examined how symptoms were measured using specific withdrawal severity scales over short, defined time intervals typical of the acute withdrawal setting.


Evidence in Specific Patient Groups, Including Older Adults

Oxapam was evaluated in specific patient groups, particularly older adults (geriatric patients), due to its distinct metabolism compared to some other medicines in its class. These studies explored how symptoms of agitation, tension, and restlessness was monitored in this population.

Research focused on outcomes related to systemic or functional imbalance and also assessed pharmacokinetic measures to determine how the drug is processed by the body in older patients. Studies reported how symptoms evolved in the observed populations, and the research highlights the necessity of using lower doses and short durations due to the increased susceptibility of older adults to certain changes.


Main Gaps and Uncertainties in the Research Evidence

Key limitations in the research landscape include the limited information for long-term outcomes and the lack of systematic data regarding the consequences of long-term administration. The evidence quality varies across studies due to the historical nature of much of the initial research. Data for certain groups remain insufficient, particularly for specialized populations beyond older adults. The research provides context on short-term changes, but the long-term impact on functional limitations is not fully characterized.

Key Studies & References

  1. Label: OXAZEPAM capsule (DailyMed - NIH) - Indications and Long-Term Use
  2. Oxazepam - StatPearls (NCBI Bookshelf) - Metabolism and Indications
  3. Oxazepam Capsules, USP (DailyMed - NIH) - Special Populations and Pharmacokinetics

Frequently Asked Questions (FAQ)

Common questions about Oxapam (FAQ)


Q: How quickly does Oxapam typically start to work?

A: According to official pharmacokinetic data, the drug is absorbed relatively quickly after use. The peak blood levels—the point at which the drug is most concentrated in the body—are typically observed about three hours after taking a dose.


Q: How long does the effect of a dose of Oxapam usually last?

A: The half-life of Oxapam is a measure of how long it takes for the body to eliminate the drug. The average elimination half-life is approximately 8.2 hours. This figure describes the time required for half of the drug to be processed and removed from the body.


Q: Does Oxapam cause drowsiness or make you feel sleepy?

A: Yes, drowsiness is listed in regulatory safety documents as a commonly reported adverse reaction, along with dizziness and headache. Official information indicates that these effects are often noted to occur during the initial days after starting therapy.


Q: Can Oxapam affect my ability to drive or operate machinery?

A: Official warnings caution against operating heavy machinery or driving until one is certain how the medicine affects alertness. This is due to the drug's potential to cause side effects like drowsiness, dizziness, and decreased alertness.


Q: Is it possible to develop tolerance to Oxapam over time?

A: Extended use of this medicine is associated with the risk of developing physical dependence. Regulatory documents note that the risks of dependence increase when the medicine is taken for longer durations or at higher daily doses.


Q: Can Oxapam be crushed, chewed, or cut?

A: Official instructions for certain tablet forms indicate that the score line on the tablet is not intended for breaking or dividing the medicine. Therefore, official instructions indicate that the dosage form is typically intended to be taken whole.


Q: Does Oxapam appear on standard drug screening tests?

A: As a benzodiazepine, regulatory sources indicate the substance is measurable. It is included in regulatory lists for some drug testing programs, such as roadside testing, which use a specified cut-off level to detect its presence.


Q: Is Oxapam the same kind of medicine as Valium or Xanax?

A: Oxapam (Oxazepam) is in the same pharmacological class, benzodiazepines, as medicines like Valium (diazepam) and Xanax (alprazolam). They are all categorized as Central Nervous System (CNS) depressants and influence activity in the nervous system.


Q: How does Oxapam compare to other medicines used for the same purpose?

A: Official medical reviews have noted that Oxapam's metabolism is minimally affected by liver function compared to many other medicines in its class. This characteristic is why it may be a specific option considered for patients with certain types of existing medical conditions.


Q: What does the box warning for Oxapam say?

A: The medication carries a Boxed Warning that highlights important safety risks and limitations. This includes risks associated with the concomitant use of opioids, risks of abuse, misuse, and addiction, and the potential for physical dependence and withdrawal reactions.


Q: Can Oxapam be used by someone with a history of substance use disorder?

A: Regulatory documents classify the medicine as a controlled substance due to its potential for abuse and dependence. Patients with a history of alcohol or drug abuse or dependence are typically considered a conditional-use population, and official guidance indicates that its suitability must be evaluated.


Q: How is Oxapam different from its metabolite?

A: Oxapam (oxazepam) is primarily metabolized in the body into a compound called oxazepam glucuronide. This metabolite is the form used for elimination from the body and is described as inactive, meaning it does not contribute significantly to the drug's therapeutic effects.


Q: What evidence is there regarding Oxapam and long-term cognitive effects?

A: Official research reviews state that information on the long-term outcomes of Oxapam is currently limited. Official research reviews indicate that the long-term impact on factors like functional limitations and cognitive function is not fully characterized.


Q: Can I take Oxapam if I am lactose intolerant?

A: Official product information states that some tablet and capsule formulations of Oxapam contain lactose monohydrate as an inactive ingredient. Patients with specific hereditary problems involving sugar intolerance should have the excipients in their prescribed formulation reviewed.


Q: Why is this medication sometimes described as a 'central nervous system depressant'?

A: It is classified as a CNS depressant because of its mechanism of action: it works by enhancing the natural inhibitory effects of a brain chemical called GABA. This process acts to slow down, or depress, overactivity within the central nervous system, leading to its calming effects.


Q: Can Oxapam affect my blood pressure?

A: Official safety documents list hypotension (low blood pressure) as a possible adverse reaction to Oxapam. This adverse reaction is noted in official documents, particularly in older adults.

How should Oxapam be stored and disposed of?

Oxapam (Oxazepam) must be stored at Controlled Room Temperature, which is officially defined as 20 C to 25 C (68 F to 77 F). Temporary temperature excursions are permitted between 15 C and 30 C (59 F and 86 F).

The medication is required to be kept in a tightly closed container and must be protected from light to maintain stability. For safety, the product must always be stored in a safe place and kept strictly out of the reach of children.

Disposal of any unused, expired, or unneeded medicine must be completed properly. Because Oxapam is a controlled substance, official labeling requires consulting a healthcare professional for the appropriate disposal method, which often involves authorized drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oxapam found in:

A-Z Index: